BDSX Q4 2024 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q4 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$20M+39.3% YoY

Gross Profit

$16M78.7% margin

Operating Income

-$7M-32.5% margin

Net Income

-$8M-40.4% margin

EPS (Diluted)

$-1.20

QoQ Revenue Growth

+12.6%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$97M

Total Liabilities

$76M

Stockholders' Equity

$21M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$15M	+39.3%
Gross Profit	$16M	$11M	+42.4%
Operating Income	-$7M	-$7M	+2.9%
Net Income	-$8M	-$9M	+9.7%